Related Experiment Video

Updated: Aug 21, 2026

Analysis of Group IV Viral SSHHPS Using In Vitro and In Silico Methods
10:40

Analysis of Group IV Viral SSHHPS Using In Vitro and In Silico Methods

Published on: December 21, 2019

Selective inhibition of enterovirus 71 replication by short hairpin RNAs

Wen-Wen Lu1, Yueh-Ying Hsu, Jyh-Yuan Yang

  • 1Faculty of Biotechnology and Laboratory Science in Medicine, Institute of Biotechnology in Medicine, National Yang-Ming University, Taipei, Taiwan, ROC.

Biochemical and Biophysical Research Communications
|November 9, 2004
PubMed

Insights

RNA interference (RNAi) therapy shows promise for treating enterovirus 71 (EV71) infections. Short hairpin RNA (shRNA) effectively inhibited EV71 replication in cell cultures, demonstrating a potential new treatment strategy.

Area of Science:

  • Molecular Biology
  • Virology
  • Gene Therapy

Background:

  • Enterovirus 71 (EV71) is a virulent pathogen causing severe complications within the Picornaviridae family.
  • RNA interference (RNAi) is a natural process for sequence-specific mRNA degradation, offering therapeutic potential.

Purpose of the Study:

  • To investigate the efficacy of RNA interference (RNAi) strategy for treating enterovirus 71 (EV71) infections.
  • To develop and evaluate short hairpin RNA (shRNA) expression plasmids for inhibiting EV71.

Main Methods:

  • Development of shRNA expression plasmids targeting EV71.
  • Transient transfection of cell cultures to assess viral protein inhibition.
  • Stable expression of shRNAs in cells to evaluate viral resistance and replication attenuation.
  • Cytotoxicity assays to confirm specificity of shRNA effect on EV71.

Main Results:

  • shRNA expression plasmids significantly inhibited EV71 protein expression in a sequence-specific and dose-dependent manner.
  • Stable shRNA expression conferred marked resistance to viral replication at all assessed stages.
  • EV71 replication was specifically attenuated by plasmid-derived shRNAs, with no significant effect on other related enteroviruses.

Conclusions:

  • RNA interference using shRNA is a feasible approach for combating EV71 infections.
  • This strategy demonstrates potential for therapeutic applications in treating EV71-associated diseases.
  • The specificity of shRNA offers a targeted therapeutic avenue against EV71.

More Related Videos

Using Click Chemistry to Measure the Effect of Viral Infection on Host-Cell RNA Synthesis09:35

Using Click Chemistry to Measure the Effect of Viral Infection on Host-Cell RNA Synthesis

Published on: August 9, 2013

Procedures for the Identification of SARS-CoV-2 Entry Inhibitors as Potential Antivirals using MLV-Based Pseudoviruses11:43

Procedures for the Identification of SARS-CoV-2 Entry Inhibitors as Potential Antivirals using MLV-Based Pseudoviruses

Published on: February 27, 2026

Related Concept Videos

Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...